SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-401721
Filing Date
2014-11-07
Accepted
2014-11-06 21:44:00
Documents
3
Period of Report
2014-11-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d815924d8k.htm 8-K 19386
2 EX-10.1 d815924dex101.htm EX-10.1 52895
3 EX-99.1 d815924dex991.htm EX-99.1 5927
  Complete submission text file 0001193125-14-401721.txt   79510
Mailing Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615
Business Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23265 | Film No.: 141202549
SIC: 2834 Pharmaceutical Preparations